{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:28:00Z","timestamp":1775759280817,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.dsx.2015.04.009","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T16:00:42Z","timestamp":1429891242000},"page":"163-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of adipokines with metabolic disorders in patients with schizophrenia: Results of comparative study with mental healthy cohort"],"prefix":"10.1016","volume":"9","author":[{"given":"Dmitry A.","family":"Tanyanskiy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan A.","family":"Martynikhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oxana P.","family":"Rotar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra O.","family":"Konradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina A.","family":"Sokolian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay G.","family":"Neznanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander D.","family":"Denisenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2015.04.009_bib0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","article-title":"Twenty-five year mortality of a community cohort with schizophrenia","volume":"196","author":"Brown","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.dsx.2015.04.009_bib0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(99)00191-7","article-title":"Mortality and causes of death in schizophrenia in Stockholm county, Sweden","volume":"45","author":"Osby","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.dsx.2015.04.009_bib0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.dsx.2015.04.009_bib0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v64n0513","article-title":"Metabolic syndrome in patients with schizophrenia","volume":"64","author":"Heiskanen","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.dsx.2015.04.009_bib0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/070674370404901106","article-title":"Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome","volume":"49","author":"Cohn","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.dsx.2015.04.009_bib0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.dsx.2015.04.009_bib0190","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ajp.160.2.290","article-title":"Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical and atypical antipsychotics","volume":"160","author":"Lindenmayer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.dsx.2015.04.009_bib0195","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/diacare.26.5.1597","article-title":"Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes","volume":"26","author":"Lean","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2015.04.009_bib0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12740\/APP\/17371","article-title":"Risk of metabolic syndrome in patients with schizophrenia: comparative study with population of bank employees in Russia","volume":"2","author":"Martynikhin","year":"2013","journal-title":"Arch Psychiatr Psychother"},{"key":"10.1016\/j.dsx.2015.04.009_bib0205","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/ATVBAHA.107.159228","article-title":"Abdominal obesity and the metabolic syndrome: contribution of global cardiometabolic risk","volume":"28","author":"Despres","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2015.04.009_bib0210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tibs.2009.06.008","article-title":"Adipokines as novel modulators of lipid metabolism","volume":"34","author":"Lago","year":"2009","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.dsx.2015.04.009_bib0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/eje.1.02175","article-title":"Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men","volume":"155","author":"Gannage-Yared","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dsx.2015.04.009_bib0220","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1096\/fj.02-0158rev","article-title":"Analysis of paradoxical observations on the association between leptin and insulin resistance","volume":"16","author":"Ceddia","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.dsx.2015.04.009_bib0225","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2015.04.009_bib0230","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.2337\/diabetes.54.11.3154","article-title":"The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects","volume":"54","author":"Bruce","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2015.04.009_bib0235","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2337\/db07-0435","article-title":"Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism","volume":"57","author":"Qiao","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2015.04.009_bib0240","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2007.05.040","article-title":"Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver","volume":"358","author":"Matsuura","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dsx.2015.04.009_bib0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0269881105056647","article-title":"Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia","volume":"20","author":"Hosojima","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.dsx.2015.04.009_bib0250","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.diabet.2008.03.003","article-title":"Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-na\u00efve schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study","volume":"34","author":"Oriot","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.dsx.2015.04.009_bib0255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(01)03026-8","article-title":"Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine","volume":"923","author":"Ardizzone","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.dsx.2015.04.009_bib0260","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.dsx.2015.04.009_bib0265","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00125-007-0696-y","article-title":"Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs","volume":"50","author":"Hampson","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2015.04.009_bib0270","doi-asserted-by":"crossref","first-page":"E624","DOI":"10.1152\/ajpendo.00502.2010","article-title":"Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism","volume":"300","author":"Oh","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dsx.2015.04.009_bib0275","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1210\/en.2005-0898","article-title":"Liver adenosine monophosphate-activated kinase-\u03b12 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin","volume":"147","author":"Andreelli","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2015.04.009_bib0280","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.dsx.2015.04.009_bib0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/met.2011.0028","article-title":"Prevalence of metabolic syndrome components in a population of bank employees from St. Petersburg, Russia","volume":"9","author":"Konradi","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.dsx.2015.04.009_bib0290","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2015.04.009_bib0295","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc06-2057","article-title":"Insulin resistance is associated with hypercortisolemia in Polinesian patients treated with antipsychotic medication","volume":"30","author":"Poa","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2015.04.009_bib0300","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1819.2005.01370.x","article-title":"Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia","volume":"59","author":"Matsuda","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.dsx.2015.04.009_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.014","article-title":"Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study","volume":"111","author":"Bai","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.dsx.2015.04.009_bib0310","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.schres.2008.09.008","article-title":"A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder","volume":"106","author":"Hanssens","year":"2008","journal-title":"Schizophr Res"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402115000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T22:32:07Z","timestamp":1566599527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402115000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1871402115000375"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2015.04.009","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of adipokines with metabolic disorders in patients with schizophrenia: Results of comparative study with mental healthy cohort","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2015.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Diabetes India. Published by Diabetes India All rights reserved.","name":"copyright","label":"Copyright"}]}}